---
title: "Windlas Biotech Ltd (WINDLAS) — Share Price, Financials & Analysis"
symbol: "WINDLAS"
company: "Windlas Biotech Ltd"
canonical: "https://tapetide.com/stocks/WINDLAS"
isin: "INE0H5O01029"
nse_symbol: "WINDLAS"
bse_code: "543329"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
market_cap_cr: 2317.55
generated_at: "2026-09-13T18:56:16.440Z"
---

# Windlas Biotech Ltd (WINDLAS)

Canonical page: https://tapetide.com/stocks/WINDLAS

## Company

- **NSE Symbol:** WINDLAS
- **BSE Code:** 543329
- **ISIN:** INE0H5O01029
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2021-08-16
- **Face Value:** ₹5
- **F&O Eligible:** No
- **Website:** windlasbiotech.com

## About

Windlas Biotech Ltd is a leading domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). The company manufactures both solid and liquid pharmaceutical dosage forms and provides a comprehensive range of CDMO services ranging from product discovery, product development, and commercial manufacturing of generic products, including complex generics.[1]

## Latest Price

- **Price:** ₹1129.25
- **Change:** -0.15 (-0.01%)
- **Open:** ₹1127.1
- **Day High:** ₹1141.9
- **Day Low:** ₹1110.75
- **Previous Close:** ₹1129.4
- **Volume:** 66749
- **As Of:** 2026-09-11T10:01:39+00:00

## Key Fundamentals

Observed at 2026-09-11T04:53:14.309016Z.

- **Market Cap:** ₹2317.55 Cr
- **Classification:** Microcap
- **P/E (reported):** 35
- **P/E (TTM):** 35.65
- **EPS (TTM):** ₹31.68
- **EPS (reported):** ₹28.52
- **Book Value:** ₹281.35
- **Price to Book:** 4.01
- **Dividend Yield:** 0.56%
- **ROE:** 11.44%
- **ROCE:** 15.65%
- **Debt to Equity:** 0.06
- **Revenue (yearly):** ₹921.9 Cr
- **Net Income:** ₹66.5 Cr
- **EBITDA:** ₹122.5 Cr
- **52-Week High:** ₹1181.9
- **52-Week Low:** ₹697.4
- **RSI (14):** 73.46

## Tapetide Score

- **Score:** 58 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Fair · Momentum: Rising
- **Percentile:** 81.3 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 69.04 | 9% |
| growth | 67.32 | 9% |
| momentum | 81.16 | 12% |
| ownership | 52.34 | 24% |
| quality | 46.78 | 22% |
| valuation | 57.34 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 19.8%
- Promoter holding has increased by 1.41% over last quarter.
- Company's working capital requirements have reduced from 21.4 days to 14.4 days

### Weaknesses

- Company has a low return on equity of 12.8% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 53.88% | -3.7% | — |
| ebitda margin growth | 2.42% | -7.77% | -6.54% | 6.24% |
| net income growth | 6.67% | 9.02% | 17% | 28% |
| revenue growth | 2.15% | 18.51% | 21% | 16% |
| roce | 1.84% | -4.98% | -9.06% | 15.07% |
| roe | 6.6% | -5.14% | 12.14% | 18.55% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 153 | 162 | 171 | 175 | 187 | 195 | 203 | 210 | 222 | 233 | 238 | 248 |
| Expenses | 134 | 142 | 149 | 154 | 164 | 170 | 177 | 184 | 194 | 209 | 213 | 221 |
| Operating Profit | 19 | 20 | 22 | 21 | 23 | 25 | 26 | 27 | 29 | 24 | 25 | 27 |
| OPM % | 12 | 13 | 13 | 12 | 12 | 13 | 13 | 13 | 13 | 10 | 11 | 11 |
| Other Income | 3 | 3 | 4 | 4 | 5 | 4 | 5 | 5 | 4 | 5 | 4 | 5 |
| Interest | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Depreciation | 3 | 3 | 4 | 6 | 6 | 7 | 8 | 7 | 8 | 8 | 8 | 7 |
| Profit before tax | 18 | 20 | 23 | 18 | 20 | 20 | 21 | 23 | 24 | 20 | 20 | 23 |
| Tax % | 23 | 24 | 25 | 26 | 23 | 24 | 22 | 24 | 25 | 25 | 21 | 23 |
| Net Profit | 14 | 15 | 17 | 13 | 16 | 15 | 16 | 18 | 18 | 15 | 16 | 18 |
| EPS in Rs | 6.75 | 7.26 | 8.15 | 6.45 | 7.49 | 7.29 | 7.77 | 8.43 | 8.45 | 7.09 | 7.59 | 8.55 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 320 | 288 | 329 | 428 | 466 | 513 | 631 | 760 | 904 | 942 |
| Expenses | 284 | 244 | 288 | 373 | 413 | 453 | 553 | 666 | 799 | 837 |
| Operating Profit | 36 | 44 | 41 | 55 | 53 | 60 | 78 | 94 | 105 | 105 |
| OPM % | 11 | 15 | 12 | 13 | 11 | 12 | 12 | 12 | 12 | 11 |
| Other Income | 5 | 2 | 1 | -29 | 7 | 10 | 13 | 18 | 18 | 18 |
| Interest | 5 | 4 | 2 | 1 | 1 | 1 | 1 | 4 | 5 | 5 |
| Depreciation | 11 | 8 | 9 | 13 | 12 | 12 | 13 | 28 | 31 | 31 |
| Profit before tax | 25 | 35 | 31 | 11 | 46 | 57 | 77 | 79 | 87 | 87 |
| Tax % | 33 | 36 | 27 | 55 | 16 | 25 | 25 | 24 | 24 | — |
| Net Profit | 17 | 22 | 22 | 5 | 39 | 43 | 58 | 61 | 66 | 66 |
| EPS in Rs | 30.24 | 35.05 | 35.03 | 7.81 | 17.69 | 20.05 | 27.95 | 28.94 | 31.48 | 31.68 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 20 | 20 | 20 | 20 | 20 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 11 | 10 | 10 | 10 | 11 |
| Reserves | 141 | 158 | 188 | 210 | 193 | 384 | 392 | 440 | 495 | 570 |
| Borrowings | 62 | 43 | 30 | 27 | 32 | 7 | 5 | 4 | 33 | 35 |
| Other Liabilities | 94 | 93 | 73 | 100 | 65 | 89 | 121 | 172 | 222 | 291 |
| Total Liabilities | 304 | 299 | 297 | 344 | 296 | 491 | 529 | 626 | 760 | 907 |
| Fixed Assets | 56 | 58 | 62 | 68 | 96 | 91 | 109 | 179 | 223 | 213 |
| CWIP | 15 | 11 | 5 | 0 | 0 | 8 | 15 | 6 | 5 | 60 |
| Investments | 121 | 123 | 121 | 121 | 23 | 65 | 107 | 173 | 223 | 268 |
| Other Assets | 111 | 107 | 110 | 154 | 177 | 327 | 298 | 268 | 308 | 366 |
| Total Assets | 304 | 299 | 297 | 344 | 296 | 491 | 529 | 626 | 760 | 907 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 7 | 39 | 22 | 21 | 11 | 9 | 61 | 109 | 68 | 105 |
| Cash from Investing Activity | -39 | -11 | -7 | -9 | -20 | -154 | -14 | -92 | -74 | -92 |
| Cash from Financing Activity | 5 | -25 | -8 | -6 | 1 | 130 | -44 | -15 | 1 | -13 |
| Net Cash Flow | -27 | 4 | 7 | 5 | -8 | -15 | 3 | 2 | -5 | 0 |
| Free Cash Flow | -8 | 28 | 12 | 11 | 6 | -6 | -9 | 71 | 16 | 37 |
| CFO/OP | 34 | 122 | 80 | 84 | 33 | 34 | 117 | 163 | 95 | 115 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 70 | 68 | 79 | 72 | 68 | 87 | 83 | 79 | 80 | 92 |
| Inventory Days | 62 | 44 | 38 | 85 | 55 | 71 | 84 | 57 | 63 | 40 |
| Days Payable | 120 | 124 | 117 | 143 | 53 | 76 | 98 | 121 | 138 | 156 |
| Cash Conversion Cycle | 13 | -12 | 0 | 13 | 70 | 82 | 69 | 15 | 6 | -24 |
| Working Capital Days | -37 | 2 | -12 | 3 | 40 | 86 | 72 | 32 | 18 | 14 |
| ROCE % | 10 | 13 | 18 | 14 | 19 | 15 | 14 | 18 | 17 | 16 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 62.82% | 62.82% | 62.82% | 62.51% | 62.51% | 62.51% | 62.34% | 62.34% | 61.99% | 61.99% | 61.9% | 63.31% |
| FIIs | 0% | 1.35% | 1.18% | 1.59% | 2% | 1.55% | 1.52% | 1.44% | 1.11% | 0.93% | 0.6% | 2.04% |
| DIIs | 10.47% | 11.71% | 11.82% | 10.35% | 9.58% | 10.26% | 10.89% | 11.21% | 11.43% | 11.44% | 11.81% | 9.84% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 21.63% | 21.21% | 21.19% | 21.76% | 21.8% | 21.54% | 21.36% | 20.87% | 21.3% | 21.29% | 21.24% | 20.44% |
| Others | 5.07% | 2.9% | 3% | 3.79% | 4.11% | 4.14% | 3.89% | 4.14% | 4.17% | 4.35% | 4.45% | 4.36% |
| No. of Shareholders | 68798 | 61900 | 51277 | 45824 | 45706 | 46590 | 46383 | 45887 | 45433 | 45461 | 44769 | 44996 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 5 / 1

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1105.46 | Buy |
| EMA (10) | 1103.4 | Buy |
| SMA (20) | 1039.97 | Buy |
| EMA (20) | 1052.95 | Buy |
| SMA (50) | 935.54 | Buy |
| EMA (50) | 968 | Buy |
| SMA (100) | 881.55 | Buy |
| EMA (100) | 910.39 | Buy |
| SMA (200) | 833.88 | Buy |
| EMA (200) | 880.55 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 73.41 | Sell |
| MACD (12,26,9) | 62.92 | Buy |
| Stochastic (14,3,3) | 78.04 | Neutral |
| ADX (14) | 45.84 | Buy |
| Williams %R (14) | -24.32 | Neutral |
| ATR (14) | 43.58 | High Volatility |
| ROC (12) | 15.42 | Buy |
| Stoch RSI (14) | 58.37 | Neutral |
| UO (7,14,28) | 47.67 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-01 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6691fd85-a169-4a57-8795-e9da4e315459.pdf) |
| 2026-08-10 | [Board Meeting Outcome for Outcome Of The Board Meeting Held On August 10 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b503ea6b-ec45-48e6-ab60-04ae3d6f8d0f.pdf) |
| 2026-08-10 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef67f542-8759-4ae3-a24d-10b5138d9fdf.pdf) |
| 2026-08-05 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d59d6f2-b3e6-4e3d-bddb-a4d9467ff946.pdf) |
| 2026-08-05 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c846eae-669d-4db1-aae7-4ce5b91f7b6a.pdf) |
| 2026-08-04 | [Board Meeting Intimation for Notice Of The Board Meeting Scheduled To Be Held On Monday August 10 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c0b0216-6de5-4945-a7e2-ccdb849ddcc4.pdf) |
| 2026-07-24 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=caa33f44-4c1a-452f-840b-7a9a53d1527c.pdf) |
| 2026-07-24 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db959cf0-614c-4868-b8de-a02b9c7f5f68.pdf) |
| 2026-07-23 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a26319a-ccda-48b4-a48b-63d539be30ea.pdf) |
| 2026-07-10 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=abf026c2-062a-48d3-8120-d58c15d1cf86.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=577d52c7-7d08-4d1d-b117-f6f688c66989.pdf) |
| 2026-05-28 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=45174d83-9118-494f-a21a-4548a272c7d6.pdf) |
| 2026-02-11 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cd8abce-163f-45cf-8d5e-c673cc38c75f.pdf) |
| 2025-11-11 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af15a375-a568-45cd-b2f3-14557f5eb0be.pdf) |
| 2025-08-21 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51042489-04e8-49af-bc65-8ab117343602.pdf) |
| 2025-05-29 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=033f6897-f54c-4fbd-b021-5ebf228531f8.pdf) |
| 2025-02-18 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2bda47f4-a13d-4a56-b28c-b27e7e5b0592.pdf) |
| 2024-11-21 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41b46a8b-ee1d-4b2b-993c-cfddb1486c5a.pdf) |
| 2024-08-20 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1888f0a0-fd60-4260-a99e-119148fafadb.pdf) |
| 2024-05-27 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a183bf81-09e0-4857-97ee-19425424f7f7.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-08-11 | [Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Recording Of Conference Call](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85de8680-ac2d-4faf-92dd-3f90ce7fd227.pdf) |
| 2026-05-22 | [Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Recording Of Conference Call](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08afaa39-babc-4ae7-822c-d85880ba1b13.pdf) |
| 2025-08-13 | [Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Recording Of Conference Call](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6caa270-5f42-4f19-ac32-913bf77520ea.pdf) |
| 2023-02-09 | [Audio Recording Of Earnings Call](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=761da174-67c4-4233-8e42-f086f402f626.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-10 | [Outcome Of The Board Meeting Held On August 10 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=198908e1-b39a-4eca-9d23-058de9af1fce.pdf) |
| 2026-05-21 | [Approval Of Audited Consolidated And Standalone Financial Results For The Year Ended March 31 2026 Along With Recommendation Of Final Dividend](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1b28800-c9ab-4875-98ec-12c57fa74e38.pdf) |
| 2026-02-05 | [Unaudited Financial Results For The Quarter Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=061117a4-6703-4854-8cce-22336ad19a32.pdf) |
| 2025-11-06 | [Outcome Of The Board Meeting Held On November 6 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d18d31a6-325e-4b38-bbbb-05d9c4c81cdf.pdf) |
| 2025-08-12 | [Approval Of Unaudited Financial Results For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f534f38-6fbe-406c-b5ff-73bd535e419b.pdf) |
| 2025-05-22 | [Results For The Quarter And Financial Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bfe20d86-cebd-4f1b-b71d-593259667026.pdf) |
| 2025-02-11 | [Outcome Of The Board Meeting Held On February 11 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9aa387a9-5f76-4a59-a553-3db0c7df9d9e.pdf) |
| 2024-11-12 | [Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41b24b41-ba1c-4a9e-a545-521b91f7ed2f.pdf) |
| 2024-08-13 | [Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35548c72-cf3b-441b-96ae-2354ae8bb1ed.pdf) |
| 2024-05-20 | [Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=88ef9b3a-51a4-49eb-b796-defaea914648.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-10 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2e03824d-518b-40ea-a396-15d2784c9924.pdf) |
| 2026-05-21 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6daae006-27bd-426e-99b2-e3894398322f.pdf) |
| 2026-02-05 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87bf83d0-65ff-42f0-b86b-cb804a354e88.pdf) |
| 2025-11-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6103d9a2-a794-4438-9a50-a1b02bb3bc10.pdf) |
| 2025-08-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a0de84a-237b-4675-8de3-3480ea84f5e9.pdf) |
| 2025-05-22 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=210ef46a-3230-49c7-b58d-37d86b85821d.pdf) |
| 2025-02-11 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=002f5a37-9c32-4bbb-ad6b-53731404b161.pdf) |
| 2024-11-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76a0e5a7-9534-493d-a553-a88f490a988a.pdf) |
| 2024-08-13 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3b22fcc-7015-4e3f-bbf3-83801badb227.pdf) |
| 2024-05-20 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35108d1d-f4b2-4e65-a6fb-ee2e8a781f69.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9h - Windlas Biotech opens ₹47 crore buyback for 4.70 lakh shares at ₹1,000 each; window April 30–May 7, 2026. | [Submission Of Letter Of Offer 9h - Windlas Biotech opens ₹47 crore buyback for 4.70 lakh shares at ₹1,000 each; window April 30–May 7, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4ef324fd-6502-489d-ba53-0315e1504150.pdf) |
| 6 Apr - Submitted Regulation 74(5) depository certificate for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 6 Apr - Submitted Regulation 74(5) depository certificate for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fa531c9d-f07e-46bd-9bab-7f1ab461234e.pdf) |
| 5 May - Dr. Tarashree Singhal appointed Independent Woman Director from May 5, 2026; Srinivasan Venkataraman steps down. | [Announcement under Regulation 30 (LODR)-Change in Directorate 5 May - Dr. Tarashree Singhal appointed Independent Woman Director from May 5, 2026; Srinivasan Venkataraman steps down.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/2487b8f8-e7d8-42b7-a300-86296fb2e182.pdf) |
| 30 Apr - Company confirmed it is not a Large Corporate for FY 2026-27 under SEBI circular. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Company confirmed it is not a Large Corporate for FY 2026-27 under SEBI circular.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6bc6b92f-3257-4e4f-a985-5f6e71dc14a8.pdf) |
| 30 Apr - Company confirmed it is not a Large Corporate for FY 2026-27 under SEBI circular. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 30 Apr - Company confirmed it is not a Large Corporate for FY 2026-27 under SEBI circular.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/6bc6b92f-3257-4e4f-a985-5f6e71dc14a8.pdf) |
| 29 Apr - Submission of newspaper publications regarding dispatch of Letter of Offer of Buyback to the shareholders of the Company | [Announcement under Regulation 30 (LODR)-Newspaper Publication 29 Apr - Submission of newspaper publications regarding dispatch of Letter of Offer of Buyback to the shareholders of the Company](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0a8298b6-ac3e-4e19-a9c3-d6cbb1df88db.pdf) |
| 29 Apr - Submission of newspaper publications regarding dispatch of Letter of Offer of Buyback to the shareholders of the Company | [Announcement under Regulation 30 (LODR)-Newspaper Publication 29 Apr - Submission of newspaper publications regarding dispatch of Letter of Offer of Buyback to the shareholders of the Company](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0a8298b6-ac3e-4e19-a9c3-d6cbb1df88db.pdf) |
| 27 Apr - Windlas Biotech opens ₹47 crore buyback for 4.70 lakh shares at ₹1,000 each; window April 30–May 7, 2026. | [Submission Of Letter Of Offer 27 Apr - Windlas Biotech opens ₹47 crore buyback for 4.70 lakh shares at ₹1,000 each; window April 30–May 7, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4ef324fd-6502-489d-ba53-0315e1504150.pdf) |
| 20 Mar - Postal ballot passed re-appointing Ashok Windlass (w.e.f May 3, 2026), Vivek Dhariwal and Gaurav Gulati (w.e.f May 6, 2026). | [Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot 20 Mar - Postal ballot passed re-appointing Ashok Windlass (w.e.f May 3, 2026), Vivek Dhariwal and Gaurav Gulati (w.e.f May 6, 2026).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/36d8d5ef-eb54-4a46-b31b-00bf02b0e855.pdf) |
| 20 Apr - Submission of Public Announcement pertaining to Buyback of shares of the Company published in newspapers and Board Resolution | [Announcement under Regulation 30 (LODR)-Newspaper Publication 20 Apr - Submission of Public Announcement pertaining to Buyback of shares of the Company published in newspapers and Board Resolution](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c4492d24-2d4d-4923-96cd-3c7755bd2288.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2021 | [Concall - Sep 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dc914a77-15b3-4f04-85dc-6ab4519565b1.pdf) |
| Sep 2021 | [Concall - Sep 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b46580d8-e6ee-406b-98ed-522bdb79a312.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/af15a375-a568-45cd-b2f3-14557f5eb0be.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/41b46a8b-ee1d-4b2b-993c-cfddb1486c5a.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e3eebe99-c41d-40aa-a2d2-d9831f708075.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f6ade46e-a504-42ee-8a84-6ecc8a6b56f8.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ff9683cf-c7d8-4561-92e6-37c2ac1fe384.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/45174d83-9118-494f-a21a-4548a272c7d6.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/45174d83-9118-494f-a21a-4548a272c7d6.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6daae006-27bd-426e-99b2-e3894398322f.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2022 from nse](https://archives.nseindia.com/annual_reports/AR_20892_WINDLAS_2021_2022_26082022211937_08262022220001.zip) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/972c5627-6db2-449e-81ea-9938d2f38f7f.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9faec512-99bd-4398-9c69-32e3ec7850bd.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dbc5721c-064f-4711-95e3-72ccdd7d7da3.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bd7c6b1b-0ff3-4380-ab2c-7d2d27c0a360.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/543329/74846543329.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:56:16.440Z.